Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca appoints Aradhana Sarin as new Chief Financial Officer
-
Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer with 43% of patients surviving five years
-
Lynparza reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial
-
Anifrolumab showed benefit across different measures of skin and joint disease activity in patients with systemic lupus erythematosus
-
Tagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
-
AstraZeneca ASCO 2021 data support ambition to revolutionise cancer outcomes by treating earlier and transforming the patient experience
-
AstraZeneca shareholders vote in favour of proposed acquisition of Alexion
-
Results of Annual General Meeting held on 11 May 2021
-
Imfinzi and tremelimumab with chemotherapy demonstrated overall survival benefit in POSEIDON trial for 1st-line Stage IV non-small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
